nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—CYP19A1—breast cancer	0.17	0.68	CbGaD
Exemestane—CYP19A1—Letrozole—breast cancer	0.09	0.26	CbGbCtD
Exemestane—CYP19A1—Anastrozole—breast cancer	0.0802	0.232	CbGbCtD
Exemestane—CYP3A4—breast cancer	0.0797	0.32	CbGaD
Exemestane—Dydrogesterone—Fluoxymesterone—breast cancer	0.0646	0.266	CrCrCtD
Exemestane—Testolactone—Fluoxymesterone—breast cancer	0.0425	0.175	CrCrCtD
Exemestane—CYP19A1—Raloxifene—breast cancer	0.0406	0.117	CbGbCtD
Exemestane—Loteprednol—Fluoxymesterone—breast cancer	0.0353	0.145	CrCrCtD
Exemestane—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0353	0.145	CrCrCtD
Exemestane—Testosterone—Fluoxymesterone—breast cancer	0.033	0.136	CrCrCtD
Exemestane—Prednisolone—Fluoxymesterone—breast cancer	0.0323	0.133	CrCrCtD
Exemestane—CYP19A1—Tamoxifen—breast cancer	0.0268	0.0774	CbGbCtD
Exemestane—CYP19A1—Paclitaxel—breast cancer	0.0209	0.0603	CbGbCtD
Exemestane—CYP3A4—Letrozole—breast cancer	0.0114	0.0329	CbGbCtD
Exemestane—CYP3A4—Anastrozole—breast cancer	0.0102	0.0294	CbGbCtD
Exemestane—CYP3A4—Toremifene—breast cancer	0.00929	0.0269	CbGbCtD
Exemestane—CYP3A4—Fulvestrant—breast cancer	0.00864	0.025	CbGbCtD
Exemestane—CYP3A4—Thiotepa—breast cancer	0.0077	0.0223	CbGbCtD
Exemestane—CYP3A4—Ixabepilone—breast cancer	0.00704	0.0204	CbGbCtD
Exemestane—CYP3A4—Lapatinib—breast cancer	0.00678	0.0196	CbGbCtD
Exemestane—CYP19A1—corpus luteum—breast cancer	0.00613	0.644	CbGeAlD
Exemestane—CYP3A4—Raloxifene—breast cancer	0.00514	0.0149	CbGbCtD
Exemestane—CYP3A4—Vinorelbine—breast cancer	0.00376	0.0109	CbGbCtD
Exemestane—CYP3A4—Tamoxifen—breast cancer	0.0034	0.00981	CbGbCtD
Exemestane—CYP3A4—Mitoxantrone—breast cancer	0.00331	0.00957	CbGbCtD
Exemestane—CYP3A4—Paclitaxel—breast cancer	0.00264	0.00764	CbGbCtD
Exemestane—CYP3A4—Irinotecan—breast cancer	0.00261	0.00753	CbGbCtD
Exemestane—CYP3A4—Vinblastine—breast cancer	0.00232	0.0067	CbGbCtD
Exemestane—CYP3A4—Docetaxel—breast cancer	0.00191	0.00552	CbGbCtD
Exemestane—CYP3A4—Doxorubicin—breast cancer	0.00142	0.00412	CbGbCtD
Exemestane—CYP19A1—endometrium—breast cancer	0.000475	0.0498	CbGeAlD
Exemestane—CYP19A1—uterus—breast cancer	0.000437	0.0459	CbGeAlD
Exemestane—CYP19A1—adipose tissue—breast cancer	0.000428	0.0449	CbGeAlD
Exemestane—CYP19A1—female reproductive system—breast cancer	0.000393	0.0413	CbGeAlD
Exemestane—CYP19A1—adrenal gland—breast cancer	0.000384	0.0403	CbGeAlD
Exemestane—CYP19A1—female gonad—breast cancer	0.000358	0.0376	CbGeAlD
Exemestane—CYP19A1—endocrine gland—breast cancer	0.000333	0.0349	CbGeAlD
Exemestane—Dydrogesterone—PGR—breast cancer	0.000287	0.108	CrCbGaD
Exemestane—CYP19A1—lymph node—breast cancer	0.00023	0.0242	CbGeAlD
Exemestane—CYP3A4—female reproductive system—breast cancer	0.000191	0.02	CbGeAlD
Exemestane—CYP3A4—endocrine gland—breast cancer	0.000161	0.0169	CbGeAlD
Exemestane—Testolactone—CYP19A1—breast cancer	0.00016	0.0599	CrCbGaD
Exemestane—Estropipate—ESR2—breast cancer	0.000149	0.0557	CrCbGaD
Exemestane—Estropipate—SHBG—breast cancer	0.000136	0.0508	CrCbGaD
Exemestane—Conjugated Estrogens—SLCO1B1—breast cancer	0.000134	0.0503	CrCbGaD
Exemestane—Estrone—SLCO1B1—breast cancer	0.000134	0.0501	CrCbGaD
Exemestane—Conjugated Estrogens—ABCC1—breast cancer	0.000111	0.0415	CrCbGaD
Exemestane—Conjugated Estrogens—COMT—breast cancer	9.97e-05	0.0373	CrCbGaD
Exemestane—Conjugated Estrogens—ESR2—breast cancer	9.3e-05	0.0348	CrCbGaD
Exemestane—Estrone—ESR2—breast cancer	9.27e-05	0.0347	CrCbGaD
Exemestane—Estropipate—ESR1—breast cancer	9.18e-05	0.0343	CrCbGaD
Exemestane—Estrone—SHBG—breast cancer	8.45e-05	0.0316	CrCbGaD
Exemestane—Estrone—CYP1B1—breast cancer	8.45e-05	0.0316	CrCbGaD
Exemestane—Conjugated Estrogens—ABCG2—breast cancer	5.85e-05	0.0219	CrCbGaD
Exemestane—Estrone—ABCG2—breast cancer	5.83e-05	0.0218	CrCbGaD
Exemestane—Conjugated Estrogens—ESR1—breast cancer	5.73e-05	0.0214	CrCbGaD
Exemestane—Estrone—ESR1—breast cancer	5.71e-05	0.0214	CrCbGaD
Exemestane—Testosterone—SHBG—breast cancer	5.14e-05	0.0192	CrCbGaD
Exemestane—Testosterone—CYP1B1—breast cancer	5.14e-05	0.0192	CrCbGaD
Exemestane—Estropipate—CYP3A4—breast cancer	4.68e-05	0.0175	CrCbGaD
Exemestane—Estrone—CYP1A1—breast cancer	4.57e-05	0.0171	CrCbGaD
Exemestane—Testosterone—AR—breast cancer	4.51e-05	0.0169	CrCbGaD
Exemestane—Methylprednisolone—CYP3A4—breast cancer	4.27e-05	0.016	CrCbGaD
Exemestane—Estropipate—ALB—breast cancer	4.09e-05	0.0153	CrCbGaD
Exemestane—Testosterone—CYP19A1—breast cancer	3.77e-05	0.0141	CrCbGaD
Exemestane—Methylprednisolone—ABCB1—breast cancer	3.55e-05	0.0133	CrCbGaD
Exemestane—Testosterone—ABCG2—breast cancer	3.54e-05	0.0133	CrCbGaD
Exemestane—Prednisone—CYP3A4—breast cancer	3.26e-05	0.0122	CrCbGaD
Exemestane—Prednisolone—CYP3A4—breast cancer	3.01e-05	0.0113	CrCbGaD
Exemestane—Conjugated Estrogens—CYP3A4—breast cancer	2.92e-05	0.0109	CrCbGaD
Exemestane—Estrone—CYP3A4—breast cancer	2.91e-05	0.0109	CrCbGaD
Exemestane—Prednisone—ALB—breast cancer	2.85e-05	0.0107	CrCbGaD
Exemestane—CYP19A1—Metabolism—NDUFS3—breast cancer	2.82e-05	0.00124	CbGpPWpGaD
Exemestane—Testosterone—CYP1A1—breast cancer	2.78e-05	0.0104	CrCbGaD
Exemestane—CYP3A4—Biological oxidations—GSTA3—breast cancer	2.77e-05	0.00122	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	2.74e-05	0.0012	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	2.73e-05	0.0012	CbGpPWpGaD
Exemestane—Prednisone—ABCB1—breast cancer	2.72e-05	0.0102	CrCbGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—MED12—breast cancer	2.71e-05	0.00119	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CHST9—breast cancer	2.65e-05	0.00117	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BCL2—breast cancer	2.62e-05	0.00115	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	2.61e-05	0.00115	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	2.59e-05	0.00114	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MDM2—breast cancer	2.58e-05	0.00114	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	2.57e-05	0.00113	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	2.56e-05	0.00112	CbGpPWpGaD
Exemestane—Estrone—ALB—breast cancer	2.54e-05	0.00952	CrCbGaD
Exemestane—CYP3A4—Biological oxidations—GSTA4—breast cancer	2.53e-05	0.00111	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	2.52e-05	0.00111	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	2.52e-05	0.00111	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—COX11—breast cancer	2.52e-05	0.00111	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MTOR—breast cancer	2.51e-05	0.0011	CbGpPWpGaD
Exemestane—Prednisolone—ABCB1—breast cancer	2.5e-05	0.00937	CrCbGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	2.5e-05	0.0011	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	2.47e-05	0.00109	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTA2—breast cancer	2.47e-05	0.00108	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—SULT1A1—breast cancer	2.44e-05	0.00107	CbGpPWpGaD
Exemestane—Conjugated Estrogens—ABCB1—breast cancer	2.43e-05	0.00911	CrCbGaD
Exemestane—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	2.43e-05	0.00107	CbGpPWpGaD
Exemestane—Estrone—ABCB1—breast cancer	2.43e-05	0.00908	CrCbGaD
Exemestane—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	2.4e-05	0.00106	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	2.4e-05	0.00106	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	2.4e-05	0.00105	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTA1—breast cancer	2.38e-05	0.00105	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—NAT2—breast cancer	2.35e-05	0.00103	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	2.32e-05	0.00102	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP3—breast cancer	2.31e-05	0.00102	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SHMT1—breast cancer	2.3e-05	0.00101	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CDA—breast cancer	2.3e-05	0.00101	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	2.27e-05	0.000999	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CCND1—breast cancer	2.25e-05	0.000989	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	2.25e-05	0.000989	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—JUN—breast cancer	2.25e-05	0.000987	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—breast cancer	2.23e-05	0.00098	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLCO1B1—breast cancer	2.21e-05	0.000974	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC2A5—breast cancer	2.21e-05	0.000974	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—PTEN—breast cancer	2.17e-05	0.000955	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	2.16e-05	0.000952	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—APRT—breast cancer	2.14e-05	0.00094	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—FASN—breast cancer	2.1e-05	0.000923	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	2.09e-05	0.000919	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	2.07e-05	0.000911	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ESRRA—breast cancer	2.01e-05	0.000884	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ANGPTL4—breast cancer	2.01e-05	0.000884	CbGpPWpGaD
Exemestane—Anorexia—Docetaxel—breast cancer	2e-05	0.000159	CcSEcCtD
Exemestane—Rhinitis—Epirubicin—breast cancer	2e-05	0.000158	CcSEcCtD
Exemestane—Urinary tract infection—Doxorubicin—breast cancer	2e-05	0.000158	CcSEcCtD
Exemestane—Nervous system disorder—Capecitabine—breast cancer	2e-05	0.000158	CcSEcCtD
Exemestane—Haemorrhage—Epirubicin—breast cancer	2e-05	0.000158	CcSEcCtD
Exemestane—Hepatitis—Epirubicin—breast cancer	2e-05	0.000158	CcSEcCtD
Exemestane—Diarrhoea—Fluorouracil—breast cancer	1.99e-05	0.000158	CcSEcCtD
Exemestane—Thrombocytopenia—Capecitabine—breast cancer	1.99e-05	0.000158	CcSEcCtD
Exemestane—Hypoaesthesia—Epirubicin—breast cancer	1.99e-05	0.000157	CcSEcCtD
Exemestane—Pharyngitis—Epirubicin—breast cancer	1.98e-05	0.000157	CcSEcCtD
Exemestane—Cardiac disorder—Methotrexate—breast cancer	1.98e-05	0.000157	CcSEcCtD
Exemestane—Skin disorder—Capecitabine—breast cancer	1.98e-05	0.000156	CcSEcCtD
Exemestane—Sweating—Doxorubicin—breast cancer	1.97e-05	0.000156	CcSEcCtD
Exemestane—Urticaria—Paclitaxel—breast cancer	1.97e-05	0.000156	CcSEcCtD
Exemestane—Hyperhidrosis—Capecitabine—breast cancer	1.97e-05	0.000156	CcSEcCtD
Exemestane—Oedema peripheral—Epirubicin—breast cancer	1.97e-05	0.000156	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—breast cancer	1.96e-05	0.000862	CbGpPWpGaD
Exemestane—Body temperature increased—Paclitaxel—breast cancer	1.96e-05	0.000155	CcSEcCtD
Exemestane—Abdominal pain—Paclitaxel—breast cancer	1.96e-05	0.000155	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	1.95e-05	0.000858	CbGpPWpGaD
Exemestane—Hepatobiliary disease—Doxorubicin—breast cancer	1.95e-05	0.000154	CcSEcCtD
Exemestane—Anorexia—Capecitabine—breast cancer	1.94e-05	0.000154	CcSEcCtD
Exemestane—Vomiting—Mitoxantrone—breast cancer	1.93e-05	0.000153	CcSEcCtD
Exemestane—Vomiting—Irinotecan—breast cancer	1.93e-05	0.000153	CcSEcCtD
Exemestane—Sinusitis—Doxorubicin—breast cancer	1.93e-05	0.000153	CcSEcCtD
Exemestane—Immune system disorder—Methotrexate—breast cancer	1.93e-05	0.000152	CcSEcCtD
Exemestane—Dizziness—Fluorouracil—breast cancer	1.93e-05	0.000152	CcSEcCtD
Exemestane—Visual impairment—Epirubicin—breast cancer	1.92e-05	0.000152	CcSEcCtD
Exemestane—Rash—Irinotecan—breast cancer	1.92e-05	0.000152	CcSEcCtD
Exemestane—Rash—Mitoxantrone—breast cancer	1.92e-05	0.000152	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—MTR—breast cancer	1.92e-05	0.000843	CbGpPWpGaD
Exemestane—Dermatitis—Irinotecan—breast cancer	1.92e-05	0.000152	CcSEcCtD
Exemestane—Dermatitis—Mitoxantrone—breast cancer	1.92e-05	0.000152	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Docetaxel—breast cancer	1.92e-05	0.000152	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.91e-05	0.000841	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HADHB—breast cancer	1.91e-05	0.000838	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GPI—breast cancer	1.91e-05	0.000838	CbGpPWpGaD
Exemestane—Headache—Mitoxantrone—breast cancer	1.91e-05	0.000151	CcSEcCtD
Exemestane—Headache—Irinotecan—breast cancer	1.91e-05	0.000151	CcSEcCtD
Exemestane—Insomnia—Docetaxel—breast cancer	1.9e-05	0.00015	CcSEcCtD
Exemestane—Paraesthesia—Docetaxel—breast cancer	1.89e-05	0.000149	CcSEcCtD
Exemestane—Erythema multiforme—Epirubicin—breast cancer	1.89e-05	0.000149	CcSEcCtD
Exemestane—Alopecia—Methotrexate—breast cancer	1.89e-05	0.000149	CcSEcCtD
Exemestane—Vomiting—Gemcitabine—breast cancer	1.88e-05	0.000149	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—HPGDS—breast cancer	1.88e-05	0.000827	CbGpPWpGaD
Exemestane—Dyspnoea—Docetaxel—breast cancer	1.87e-05	0.000148	CcSEcCtD
Exemestane—Mental disorder—Methotrexate—breast cancer	1.87e-05	0.000148	CcSEcCtD
Exemestane—Rash—Gemcitabine—breast cancer	1.87e-05	0.000148	CcSEcCtD
Exemestane—Dermatitis—Gemcitabine—breast cancer	1.87e-05	0.000148	CcSEcCtD
Exemestane—Haemoglobin—Doxorubicin—breast cancer	1.86e-05	0.000147	CcSEcCtD
Exemestane—Headache—Gemcitabine—breast cancer	1.86e-05	0.000147	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Capecitabine—breast cancer	1.86e-05	0.000147	CcSEcCtD
Exemestane—Cardiac disorder—Epirubicin—breast cancer	1.85e-05	0.000147	CcSEcCtD
Exemestane—Vomiting—Fluorouracil—breast cancer	1.85e-05	0.000147	CcSEcCtD
Exemestane—Rhinitis—Doxorubicin—breast cancer	1.85e-05	0.000146	CcSEcCtD
Exemestane—Dyspepsia—Docetaxel—breast cancer	1.85e-05	0.000146	CcSEcCtD
Exemestane—Haemorrhage—Doxorubicin—breast cancer	1.85e-05	0.000146	CcSEcCtD
Exemestane—Hepatitis—Doxorubicin—breast cancer	1.85e-05	0.000146	CcSEcCtD
Exemestane—Insomnia—Capecitabine—breast cancer	1.84e-05	0.000146	CcSEcCtD
Exemestane—Hypoaesthesia—Doxorubicin—breast cancer	1.84e-05	0.000145	CcSEcCtD
Exemestane—Rash—Fluorouracil—breast cancer	1.84e-05	0.000145	CcSEcCtD
Exemestane—Dermatitis—Fluorouracil—breast cancer	1.84e-05	0.000145	CcSEcCtD
Exemestane—Pharyngitis—Doxorubicin—breast cancer	1.83e-05	0.000145	CcSEcCtD
Exemestane—Paraesthesia—Capecitabine—breast cancer	1.83e-05	0.000145	CcSEcCtD
Exemestane—Decreased appetite—Docetaxel—breast cancer	1.83e-05	0.000145	CcSEcCtD
Exemestane—Hypersensitivity—Paclitaxel—breast cancer	1.83e-05	0.000145	CcSEcCtD
Exemestane—Headache—Fluorouracil—breast cancer	1.83e-05	0.000144	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.82e-05	0.000802	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTT1—breast cancer	1.82e-05	0.000802	CbGpPWpGaD
Exemestane—Oedema peripheral—Doxorubicin—breast cancer	1.82e-05	0.000144	CcSEcCtD
Exemestane—CYP19A1—Metabolism—ALDH1A1—breast cancer	1.82e-05	0.0008	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALDH7A1—breast cancer	1.82e-05	0.0008	CbGpPWpGaD
Exemestane—Gastrointestinal disorder—Docetaxel—breast cancer	1.82e-05	0.000144	CcSEcCtD
Exemestane—Dyspnoea—Capecitabine—breast cancer	1.82e-05	0.000144	CcSEcCtD
Exemestane—Fatigue—Docetaxel—breast cancer	1.81e-05	0.000143	CcSEcCtD
Exemestane—Nausea—Irinotecan—breast cancer	1.81e-05	0.000143	CcSEcCtD
Exemestane—Nausea—Mitoxantrone—breast cancer	1.81e-05	0.000143	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MYC—breast cancer	1.81e-05	0.000793	CbGpPWpGaD
Exemestane—Immune system disorder—Epirubicin—breast cancer	1.8e-05	0.000143	CcSEcCtD
Exemestane—Constipation—Docetaxel—breast cancer	1.8e-05	0.000142	CcSEcCtD
Exemestane—Pain—Docetaxel—breast cancer	1.8e-05	0.000142	CcSEcCtD
Exemestane—Back pain—Methotrexate—breast cancer	1.8e-05	0.000142	CcSEcCtD
Exemestane—Dyspepsia—Capecitabine—breast cancer	1.79e-05	0.000142	CcSEcCtD
Exemestane—Visual impairment—Doxorubicin—breast cancer	1.78e-05	0.000141	CcSEcCtD
Exemestane—Asthenia—Paclitaxel—breast cancer	1.78e-05	0.000141	CcSEcCtD
Exemestane—Testosterone—CYP3A4—breast cancer	1.77e-05	0.00663	CrCbGaD
Exemestane—Decreased appetite—Capecitabine—breast cancer	1.77e-05	0.00014	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EGFR—breast cancer	1.77e-05	0.000776	CbGpPWpGaD
Exemestane—Alopecia—Epirubicin—breast cancer	1.76e-05	0.00014	CcSEcCtD
Exemestane—Nausea—Gemcitabine—breast cancer	1.76e-05	0.000139	CcSEcCtD
Exemestane—Gastrointestinal disorder—Capecitabine—breast cancer	1.76e-05	0.000139	CcSEcCtD
Exemestane—Fatigue—Capecitabine—breast cancer	1.76e-05	0.000139	CcSEcCtD
Exemestane—Pruritus—Paclitaxel—breast cancer	1.76e-05	0.000139	CcSEcCtD
Exemestane—Mental disorder—Epirubicin—breast cancer	1.75e-05	0.000138	CcSEcCtD
Exemestane—Erythema multiforme—Doxorubicin—breast cancer	1.75e-05	0.000138	CcSEcCtD
Exemestane—CYP19A1—Metabolism—FHL2—breast cancer	1.74e-05	0.000767	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NME1—breast cancer	1.74e-05	0.000767	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—UMPS—breast cancer	1.74e-05	0.000767	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADSL—breast cancer	1.74e-05	0.000767	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PHGDH—breast cancer	1.74e-05	0.000767	CbGpPWpGaD
Exemestane—Constipation—Capecitabine—breast cancer	1.74e-05	0.000138	CcSEcCtD
Exemestane—Pain—Capecitabine—breast cancer	1.74e-05	0.000138	CcSEcCtD
Exemestane—Feeling abnormal—Docetaxel—breast cancer	1.73e-05	0.000137	CcSEcCtD
Exemestane—Nausea—Fluorouracil—breast cancer	1.73e-05	0.000137	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP17A1—breast cancer	1.73e-05	0.000759	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Docetaxel—breast cancer	1.72e-05	0.000136	CcSEcCtD
Exemestane—Cardiac disorder—Doxorubicin—breast cancer	1.71e-05	0.000136	CcSEcCtD
Exemestane—CYP19A1—Metabolism—HPSE—breast cancer	1.71e-05	0.000752	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—BRIP1—breast cancer	1.71e-05	0.000752	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—LDHB—breast cancer	1.71e-05	0.000752	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—PTGS1—breast cancer	1.71e-05	0.000751	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	1.7e-05	0.000748	CbGpPWpGaD
Exemestane—Diarrhoea—Paclitaxel—breast cancer	1.7e-05	0.000134	CcSEcCtD
Exemestane—Back pain—Epirubicin—breast cancer	1.68e-05	0.000133	CcSEcCtD
Exemestane—Feeling abnormal—Capecitabine—breast cancer	1.68e-05	0.000133	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP2D6—breast cancer	1.68e-05	0.000737	CbGpPWpGaD
Exemestane—Malaise—Methotrexate—breast cancer	1.67e-05	0.000132	CcSEcCtD
Exemestane—Muscle spasms—Epirubicin—breast cancer	1.67e-05	0.000132	CcSEcCtD
Exemestane—Immune system disorder—Doxorubicin—breast cancer	1.67e-05	0.000132	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—KRAS—breast cancer	1.67e-05	0.000733	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Capecitabine—breast cancer	1.66e-05	0.000132	CcSEcCtD
Exemestane—Abdominal pain—Docetaxel—breast cancer	1.66e-05	0.000131	CcSEcCtD
Exemestane—Body temperature increased—Docetaxel—breast cancer	1.66e-05	0.000131	CcSEcCtD
Exemestane—Leukopenia—Methotrexate—breast cancer	1.66e-05	0.000131	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	1.65e-05	0.000727	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—NCOA2—breast cancer	1.65e-05	0.000723	CbGpPWpGaD
Exemestane—Dizziness—Paclitaxel—breast cancer	1.64e-05	0.00013	CcSEcCtD
Exemestane—Alopecia—Doxorubicin—breast cancer	1.63e-05	0.000129	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GSTA3—breast cancer	1.62e-05	0.000713	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCC1—breast cancer	1.62e-05	0.000713	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMMR—breast cancer	1.62e-05	0.000713	CbGpPWpGaD
Exemestane—Cough—Methotrexate—breast cancer	1.62e-05	0.000128	CcSEcCtD
Exemestane—Mental disorder—Doxorubicin—breast cancer	1.62e-05	0.000128	CcSEcCtD
Exemestane—Urticaria—Capecitabine—breast cancer	1.62e-05	0.000128	CcSEcCtD
Exemestane—Abdominal pain—Capecitabine—breast cancer	1.61e-05	0.000127	CcSEcCtD
Exemestane—Body temperature increased—Capecitabine—breast cancer	1.61e-05	0.000127	CcSEcCtD
Exemestane—Arthralgia—Methotrexate—breast cancer	1.58e-05	0.000125	CcSEcCtD
Exemestane—Chest pain—Methotrexate—breast cancer	1.58e-05	0.000125	CcSEcCtD
Exemestane—Myalgia—Methotrexate—breast cancer	1.58e-05	0.000125	CcSEcCtD
Exemestane—Vomiting—Paclitaxel—breast cancer	1.58e-05	0.000125	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.57e-05	0.000124	CcSEcCtD
Exemestane—CYP19A1—Metabolism—PPARGC1B—breast cancer	1.57e-05	0.00069	CbGpPWpGaD
Exemestane—Malaise—Epirubicin—breast cancer	1.57e-05	0.000124	CcSEcCtD
Exemestane—Rash—Paclitaxel—breast cancer	1.56e-05	0.000124	CcSEcCtD
Exemestane—Dermatitis—Paclitaxel—breast cancer	1.56e-05	0.000124	CcSEcCtD
Exemestane—Leukopenia—Epirubicin—breast cancer	1.56e-05	0.000123	CcSEcCtD
Exemestane—Back pain—Doxorubicin—breast cancer	1.56e-05	0.000123	CcSEcCtD
Exemestane—Headache—Paclitaxel—breast cancer	1.55e-05	0.000123	CcSEcCtD
Exemestane—Hypersensitivity—Docetaxel—breast cancer	1.55e-05	0.000123	CcSEcCtD
Exemestane—Muscle spasms—Doxorubicin—breast cancer	1.55e-05	0.000122	CcSEcCtD
Exemestane—Testosterone—ALB—breast cancer	1.55e-05	0.00579	CrCbGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.53e-05	0.000672	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.53e-05	0.000672	CbGpPWpGaD
Exemestane—Confusional state—Methotrexate—breast cancer	1.53e-05	0.000121	CcSEcCtD
Exemestane—Cough—Epirubicin—breast cancer	1.52e-05	0.00012	CcSEcCtD
Exemestane—Asthenia—Docetaxel—breast cancer	1.51e-05	0.000119	CcSEcCtD
Exemestane—Infection—Methotrexate—breast cancer	1.51e-05	0.000119	CcSEcCtD
Exemestane—Hypertension—Epirubicin—breast cancer	1.5e-05	0.000119	CcSEcCtD
Exemestane—Hypersensitivity—Capecitabine—breast cancer	1.5e-05	0.000119	CcSEcCtD
Exemestane—Pruritus—Docetaxel—breast cancer	1.49e-05	0.000118	CcSEcCtD
Exemestane—Nervous system disorder—Methotrexate—breast cancer	1.49e-05	0.000118	CcSEcCtD
Exemestane—Thrombocytopenia—Methotrexate—breast cancer	1.48e-05	0.000117	CcSEcCtD
Exemestane—CYP19A1—Metabolism—CA9—breast cancer	1.48e-05	0.000652	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA4—breast cancer	1.48e-05	0.000652	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TP53—breast cancer	1.48e-05	0.000652	CbGpPWpGaD
Exemestane—Arthralgia—Epirubicin—breast cancer	1.48e-05	0.000117	CcSEcCtD
Exemestane—Chest pain—Epirubicin—breast cancer	1.48e-05	0.000117	CcSEcCtD
Exemestane—Myalgia—Epirubicin—breast cancer	1.48e-05	0.000117	CcSEcCtD
Exemestane—Testosterone—ABCB1—breast cancer	1.48e-05	0.00552	CrCbGaD
Exemestane—Anxiety—Epirubicin—breast cancer	1.47e-05	0.000117	CcSEcCtD
Exemestane—Nausea—Paclitaxel—breast cancer	1.47e-05	0.000117	CcSEcCtD
Exemestane—Skin disorder—Methotrexate—breast cancer	1.47e-05	0.000116	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.47e-05	0.000116	CcSEcCtD
Exemestane—Hyperhidrosis—Methotrexate—breast cancer	1.47e-05	0.000116	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.46e-05	0.000644	CbGpPWpGaD
Exemestane—Asthenia—Capecitabine—breast cancer	1.46e-05	0.000116	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP1B1—breast cancer	1.45e-05	0.000639	CbGpPWpGaD
Exemestane—Malaise—Doxorubicin—breast cancer	1.45e-05	0.000115	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.45e-05	0.000637	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA2—breast cancer	1.44e-05	0.000635	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GPX2—breast cancer	1.44e-05	0.000635	CbGpPWpGaD
Exemestane—Anorexia—Methotrexate—breast cancer	1.44e-05	0.000114	CcSEcCtD
Exemestane—Pruritus—Capecitabine—breast cancer	1.44e-05	0.000114	CcSEcCtD
Exemestane—Leukopenia—Doxorubicin—breast cancer	1.44e-05	0.000114	CcSEcCtD
Exemestane—Diarrhoea—Docetaxel—breast cancer	1.44e-05	0.000114	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	1.43e-05	0.00063	CbGpPWpGaD
Exemestane—Confusional state—Epirubicin—breast cancer	1.43e-05	0.000113	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GPX4—breast cancer	1.43e-05	0.000627	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SULT1A1—breast cancer	1.43e-05	0.000627	CbGpPWpGaD
Exemestane—Oedema—Epirubicin—breast cancer	1.42e-05	0.000112	CcSEcCtD
Exemestane—Infection—Epirubicin—breast cancer	1.41e-05	0.000111	CcSEcCtD
Exemestane—Cough—Doxorubicin—breast cancer	1.4e-05	0.000111	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GSTA1—breast cancer	1.39e-05	0.000613	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—IDH1—breast cancer	1.39e-05	0.000613	CbGpPWpGaD
Exemestane—Diarrhoea—Capecitabine—breast cancer	1.39e-05	0.00011	CcSEcCtD
Exemestane—Nervous system disorder—Epirubicin—breast cancer	1.39e-05	0.00011	CcSEcCtD
Exemestane—Dizziness—Docetaxel—breast cancer	1.39e-05	0.00011	CcSEcCtD
Exemestane—Thrombocytopenia—Epirubicin—breast cancer	1.39e-05	0.00011	CcSEcCtD
Exemestane—Hypertension—Doxorubicin—breast cancer	1.39e-05	0.00011	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—NCOA1—breast cancer	1.39e-05	0.000609	CbGpPWpGaD
Exemestane—Musculoskeletal discomfort—Methotrexate—breast cancer	1.38e-05	0.000109	CcSEcCtD
Exemestane—CYP19A1—Metabolism—NAT2—breast cancer	1.38e-05	0.000606	CbGpPWpGaD
Exemestane—Skin disorder—Epirubicin—breast cancer	1.38e-05	0.000109	CcSEcCtD
Exemestane—Hyperhidrosis—Epirubicin—breast cancer	1.37e-05	0.000108	CcSEcCtD
Exemestane—Insomnia—Methotrexate—breast cancer	1.37e-05	0.000108	CcSEcCtD
Exemestane—Chest pain—Doxorubicin—breast cancer	1.37e-05	0.000108	CcSEcCtD
Exemestane—Arthralgia—Doxorubicin—breast cancer	1.37e-05	0.000108	CcSEcCtD
Exemestane—Myalgia—Doxorubicin—breast cancer	1.37e-05	0.000108	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP19A1—breast cancer	1.37e-05	0.000601	CbGpPWpGaD
Exemestane—Anxiety—Doxorubicin—breast cancer	1.36e-05	0.000108	CcSEcCtD
Exemestane—Paraesthesia—Methotrexate—breast cancer	1.36e-05	0.000108	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.36e-05	0.000108	CcSEcCtD
Exemestane—Anorexia—Epirubicin—breast cancer	1.35e-05	0.000107	CcSEcCtD
Exemestane—Dyspnoea—Methotrexate—breast cancer	1.35e-05	0.000107	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	1.35e-05	0.000592	CbGpPWpGaD
Exemestane—Dizziness—Capecitabine—breast cancer	1.35e-05	0.000107	CcSEcCtD
Exemestane—Vomiting—Docetaxel—breast cancer	1.34e-05	0.000106	CcSEcCtD
Exemestane—Dyspepsia—Methotrexate—breast cancer	1.33e-05	0.000106	CcSEcCtD
Exemestane—Rash—Docetaxel—breast cancer	1.33e-05	0.000105	CcSEcCtD
Exemestane—Dermatitis—Docetaxel—breast cancer	1.32e-05	0.000105	CcSEcCtD
Exemestane—Confusional state—Doxorubicin—breast cancer	1.32e-05	0.000105	CcSEcCtD
Exemestane—Decreased appetite—Methotrexate—breast cancer	1.32e-05	0.000104	CcSEcCtD
Exemestane—Headache—Docetaxel—breast cancer	1.32e-05	0.000104	CcSEcCtD
Exemestane—Oedema—Doxorubicin—breast cancer	1.31e-05	0.000104	CcSEcCtD
Exemestane—Gastrointestinal disorder—Methotrexate—breast cancer	1.31e-05	0.000104	CcSEcCtD
Exemestane—Fatigue—Methotrexate—breast cancer	1.31e-05	0.000103	CcSEcCtD
Exemestane—Infection—Doxorubicin—breast cancer	1.3e-05	0.000103	CcSEcCtD
Exemestane—Pain—Methotrexate—breast cancer	1.3e-05	0.000103	CcSEcCtD
Exemestane—Vomiting—Capecitabine—breast cancer	1.29e-05	0.000102	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Epirubicin—breast cancer	1.29e-05	0.000102	CcSEcCtD
Exemestane—Nervous system disorder—Doxorubicin—breast cancer	1.29e-05	0.000102	CcSEcCtD
Exemestane—Thrombocytopenia—Doxorubicin—breast cancer	1.29e-05	0.000102	CcSEcCtD
Exemestane—Rash—Capecitabine—breast cancer	1.28e-05	0.000102	CcSEcCtD
Exemestane—Insomnia—Epirubicin—breast cancer	1.28e-05	0.000101	CcSEcCtD
Exemestane—Dermatitis—Capecitabine—breast cancer	1.28e-05	0.000101	CcSEcCtD
Exemestane—Headache—Capecitabine—breast cancer	1.28e-05	0.000101	CcSEcCtD
Exemestane—Skin disorder—Doxorubicin—breast cancer	1.27e-05	0.000101	CcSEcCtD
Exemestane—Paraesthesia—Epirubicin—breast cancer	1.27e-05	0.000101	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—COMT—breast cancer	1.27e-05	0.000558	CbGpPWpGaD
Exemestane—Hyperhidrosis—Doxorubicin—breast cancer	1.27e-05	0.0001	CcSEcCtD
Exemestane—Dyspnoea—Epirubicin—breast cancer	1.26e-05	0.0001	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.26e-05	0.000556	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.25e-05	0.000551	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AKT1—breast cancer	1.25e-05	0.00055	CbGpPWpGaD
Exemestane—Anorexia—Doxorubicin—breast cancer	1.25e-05	9.9e-05	CcSEcCtD
Exemestane—Nausea—Docetaxel—breast cancer	1.25e-05	9.88e-05	CcSEcCtD
Exemestane—Feeling abnormal—Methotrexate—breast cancer	1.25e-05	9.88e-05	CcSEcCtD
Exemestane—Dyspepsia—Epirubicin—breast cancer	1.25e-05	9.88e-05	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.25e-05	0.000548	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.25e-05	0.000548	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Methotrexate—breast cancer	1.24e-05	9.8e-05	CcSEcCtD
Exemestane—Decreased appetite—Epirubicin—breast cancer	1.23e-05	9.75e-05	CcSEcCtD
Exemestane—Gastrointestinal disorder—Epirubicin—breast cancer	1.22e-05	9.69e-05	CcSEcCtD
Exemestane—Fatigue—Epirubicin—breast cancer	1.22e-05	9.67e-05	CcSEcCtD
Exemestane—Constipation—Epirubicin—breast cancer	1.21e-05	9.59e-05	CcSEcCtD
Exemestane—Pain—Epirubicin—breast cancer	1.21e-05	9.59e-05	CcSEcCtD
Exemestane—Nausea—Capecitabine—breast cancer	1.21e-05	9.57e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—DPYD—breast cancer	1.21e-05	0.000531	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MED12—breast cancer	1.21e-05	0.000531	CbGpPWpGaD
Exemestane—Urticaria—Methotrexate—breast cancer	1.2e-05	9.52e-05	CcSEcCtD
Exemestane—Abdominal pain—Methotrexate—breast cancer	1.2e-05	9.48e-05	CcSEcCtD
Exemestane—Body temperature increased—Methotrexate—breast cancer	1.2e-05	9.48e-05	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.2e-05	9.46e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—ALDOA—breast cancer	1.19e-05	0.000523	CbGpPWpGaD
Exemestane—Insomnia—Doxorubicin—breast cancer	1.19e-05	9.39e-05	CcSEcCtD
Exemestane—Paraesthesia—Doxorubicin—breast cancer	1.18e-05	9.32e-05	CcSEcCtD
Exemestane—Dyspnoea—Doxorubicin—breast cancer	1.17e-05	9.26e-05	CcSEcCtD
Exemestane—Feeling abnormal—Epirubicin—breast cancer	1.17e-05	9.25e-05	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.16e-05	0.000511	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Epirubicin—breast cancer	1.16e-05	9.17e-05	CcSEcCtD
Exemestane—Dyspepsia—Doxorubicin—breast cancer	1.16e-05	9.14e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—NCOA3—breast cancer	1.16e-05	0.000508	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC2A2—breast cancer	1.15e-05	0.000504	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.15e-05	0.000504	CbGpPWpGaD
Exemestane—Decreased appetite—Doxorubicin—breast cancer	1.14e-05	9.02e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.14e-05	0.000499	CbGpPWpGaD
Exemestane—Gastrointestinal disorder—Doxorubicin—breast cancer	1.13e-05	8.96e-05	CcSEcCtD
Exemestane—Fatigue—Doxorubicin—breast cancer	1.13e-05	8.95e-05	CcSEcCtD
Exemestane—Urticaria—Epirubicin—breast cancer	1.13e-05	8.91e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—CPT1A—breast cancer	1.12e-05	0.000494	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTR—breast cancer	1.12e-05	0.000494	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCG2—breast cancer	1.12e-05	0.000494	CbGpPWpGaD
Exemestane—Constipation—Doxorubicin—breast cancer	1.12e-05	8.88e-05	CcSEcCtD
Exemestane—Pain—Doxorubicin—breast cancer	1.12e-05	8.88e-05	CcSEcCtD
Exemestane—Body temperature increased—Epirubicin—breast cancer	1.12e-05	8.87e-05	CcSEcCtD
Exemestane—Abdominal pain—Epirubicin—breast cancer	1.12e-05	8.87e-05	CcSEcCtD
Exemestane—Hypersensitivity—Methotrexate—breast cancer	1.12e-05	8.83e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—HPGDS—breast cancer	1.1e-05	0.000484	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.1e-05	0.000484	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HBA1—breast cancer	1.1e-05	0.000481	CbGpPWpGaD
Exemestane—Asthenia—Methotrexate—breast cancer	1.09e-05	8.6e-05	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.09e-05	0.000477	CbGpPWpGaD
Exemestane—Feeling abnormal—Doxorubicin—breast cancer	1.08e-05	8.55e-05	CcSEcCtD
Exemestane—Gastrointestinal pain—Doxorubicin—breast cancer	1.07e-05	8.49e-05	CcSEcCtD
Exemestane—Pruritus—Methotrexate—breast cancer	1.07e-05	8.48e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GSTT1—breast cancer	1.07e-05	0.00047	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ACHE—breast cancer	1.07e-05	0.00047	CbGpPWpGaD
Exemestane—Hypersensitivity—Epirubicin—breast cancer	1.05e-05	8.27e-05	CcSEcCtD
Exemestane—Urticaria—Doxorubicin—breast cancer	1.04e-05	8.25e-05	CcSEcCtD
Exemestane—Abdominal pain—Doxorubicin—breast cancer	1.04e-05	8.21e-05	CcSEcCtD
Exemestane—Body temperature increased—Doxorubicin—breast cancer	1.04e-05	8.21e-05	CcSEcCtD
Exemestane—Diarrhoea—Methotrexate—breast cancer	1.04e-05	8.2e-05	CcSEcCtD
Exemestane—Asthenia—Epirubicin—breast cancer	1.02e-05	8.05e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—CYP17A1—breast cancer	1.01e-05	0.000445	CbGpPWpGaD
Exemestane—Pruritus—Epirubicin—breast cancer	1e-05	7.94e-05	CcSEcCtD
Exemestane—Dizziness—Methotrexate—breast cancer	1e-05	7.93e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—PTGS1—breast cancer	1e-05	0.00044	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ENO1—breast cancer	1e-05	0.00044	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	9.98e-06	0.000439	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	9.85e-06	0.000433	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2D6—breast cancer	9.82e-06	0.000432	CbGpPWpGaD
Exemestane—Diarrhoea—Epirubicin—breast cancer	9.71e-06	7.68e-05	CcSEcCtD
Exemestane—Hypersensitivity—Doxorubicin—breast cancer	9.67e-06	7.65e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—NCOA2—breast cancer	9.64e-06	0.000424	CbGpPWpGaD
Exemestane—Vomiting—Methotrexate—breast cancer	9.64e-06	7.62e-05	CcSEcCtD
Exemestane—Rash—Methotrexate—breast cancer	9.56e-06	7.56e-05	CcSEcCtD
Exemestane—Dermatitis—Methotrexate—breast cancer	9.55e-06	7.55e-05	CcSEcCtD
Exemestane—Headache—Methotrexate—breast cancer	9.5e-06	7.51e-05	CcSEcCtD
Exemestane—Asthenia—Doxorubicin—breast cancer	9.42e-06	7.45e-05	CcSEcCtD
Exemestane—Dizziness—Epirubicin—breast cancer	9.38e-06	7.42e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—FASN—breast cancer	9.35e-06	0.000411	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—BCHE—breast cancer	9.31e-06	0.000409	CbGpPWpGaD
Exemestane—Pruritus—Doxorubicin—breast cancer	9.29e-06	7.34e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—SLC5A5—breast cancer	9.2e-06	0.000404	CbGpPWpGaD
Exemestane—Vomiting—Epirubicin—breast cancer	9.02e-06	7.13e-05	CcSEcCtD
Exemestane—Nausea—Methotrexate—breast cancer	9e-06	7.12e-05	CcSEcCtD
Exemestane—Diarrhoea—Doxorubicin—breast cancer	8.98e-06	7.1e-05	CcSEcCtD
Exemestane—Rash—Epirubicin—breast cancer	8.94e-06	7.07e-05	CcSEcCtD
Exemestane—Dermatitis—Epirubicin—breast cancer	8.94e-06	7.07e-05	CcSEcCtD
Exemestane—Headache—Epirubicin—breast cancer	8.89e-06	7.03e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—NQO1—breast cancer	8.88e-06	0.00039	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC2A1—breast cancer	8.88e-06	0.00039	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SYNJ2—breast cancer	8.86e-06	0.000389	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	8.7e-06	0.000382	CbGpPWpGaD
Exemestane—Dizziness—Doxorubicin—breast cancer	8.68e-06	6.87e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—CYP3A4—breast cancer	8.66e-06	0.000381	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	8.62e-06	0.000379	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1B1—breast cancer	8.52e-06	0.000374	CbGpPWpGaD
Exemestane—Nausea—Epirubicin—breast cancer	8.43e-06	6.66e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—HSP90AA1—breast cancer	8.35e-06	0.000367	CbGpPWpGaD
Exemestane—Vomiting—Doxorubicin—breast cancer	8.34e-06	6.6e-05	CcSEcCtD
Exemestane—Rash—Doxorubicin—breast cancer	8.28e-06	6.55e-05	CcSEcCtD
Exemestane—Dermatitis—Doxorubicin—breast cancer	8.27e-06	6.54e-05	CcSEcCtD
Exemestane—CYP3A4—Metabolism—NDUFS3—breast cancer	8.24e-06	0.000362	CbGpPWpGaD
Exemestane—Headache—Doxorubicin—breast cancer	8.22e-06	6.5e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—NCOA1—breast cancer	8.12e-06	0.000357	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—STK11—breast cancer	8.01e-06	0.000352	CbGpPWpGaD
Exemestane—Nausea—Doxorubicin—breast cancer	7.8e-06	6.17e-05	CcSEcCtD
Exemestane—CYP3A4—Metabolism—CHST9—breast cancer	7.74e-06	0.00034	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.52e-06	0.00033	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—COMT—breast cancer	7.44e-06	0.000327	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTP1—breast cancer	7.41e-06	0.000326	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—COX11—breast cancer	7.34e-06	0.000323	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMOX1—breast cancer	7.31e-06	0.000321	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ITPR1—breast cancer	7.29e-06	0.00032	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCB1—breast cancer	7.01e-06	0.000308	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TYMS—breast cancer	6.89e-06	0.000303	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PLA2G4A—breast cancer	6.81e-06	0.000299	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NCOR1—breast cancer	6.81e-06	0.000299	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTM1—breast cancer	6.81e-06	0.000299	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CDA—breast cancer	6.71e-06	0.000295	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SHMT1—breast cancer	6.71e-06	0.000295	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GPX1—breast cancer	6.52e-06	0.000287	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC2A5—breast cancer	6.46e-06	0.000284	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLCO1B1—breast cancer	6.46e-06	0.000284	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1A1—breast cancer	6.45e-06	0.000284	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ERCC2—breast cancer	6.4e-06	0.000281	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—APRT—breast cancer	6.24e-06	0.000274	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTHFR—breast cancer	6.02e-06	0.000264	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ESRRA—breast cancer	5.87e-06	0.000258	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ANGPTL4—breast cancer	5.87e-06	0.000258	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HADHB—breast cancer	5.56e-06	0.000245	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GPI—breast cancer	5.56e-06	0.000245	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CAV1—breast cancer	5.55e-06	0.000244	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.31e-06	0.000233	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.31e-06	0.000233	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.3e-06	0.000233	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—FHL2—breast cancer	5.09e-06	0.000224	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UMPS—breast cancer	5.09e-06	0.000224	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADSL—breast cancer	5.09e-06	0.000224	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NME1—breast cancer	5.09e-06	0.000224	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PHGDH—breast cancer	5.09e-06	0.000224	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CG—breast cancer	5.06e-06	0.000222	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HPSE—breast cancer	4.99e-06	0.000219	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—BRIP1—breast cancer	4.99e-06	0.000219	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—LDHB—breast cancer	4.99e-06	0.000219	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMMR—breast cancer	4.73e-06	0.000208	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCC1—breast cancer	4.73e-06	0.000208	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA3—breast cancer	4.73e-06	0.000208	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.58e-06	0.000201	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CD—breast cancer	4.44e-06	0.000195	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALB—breast cancer	4.39e-06	0.000193	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA4—breast cancer	4.33e-06	0.00019	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CA9—breast cancer	4.33e-06	0.00019	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA2—breast cancer	4.22e-06	0.000185	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GPX2—breast cancer	4.22e-06	0.000185	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NOS3—breast cancer	4.2e-06	0.000184	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GPX4—breast cancer	4.17e-06	0.000183	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SULT1A1—breast cancer	4.17e-06	0.000183	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—IDH1—breast cancer	4.07e-06	0.000179	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA1—breast cancer	4.07e-06	0.000179	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NAT2—breast cancer	4.02e-06	0.000177	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CB—breast cancer	3.87e-06	0.00017	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTGS2—breast cancer	3.84e-06	0.000169	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MED12—breast cancer	3.53e-06	0.000155	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—DPYD—breast cancer	3.53e-06	0.000155	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDOA—breast cancer	3.47e-06	0.000153	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOA3—breast cancer	3.37e-06	0.000148	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC2A2—breast cancer	3.35e-06	0.000147	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTEN—breast cancer	3.35e-06	0.000147	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCG2—breast cancer	3.28e-06	0.000144	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTR—breast cancer	3.28e-06	0.000144	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CPT1A—breast cancer	3.28e-06	0.000144	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HPGDS—breast cancer	3.22e-06	0.000141	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HBA1—breast cancer	3.2e-06	0.00014	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ACHE—breast cancer	3.12e-06	0.000137	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTT1—breast cancer	3.12e-06	0.000137	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP17A1—breast cancer	2.95e-06	0.00013	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTGS1—breast cancer	2.92e-06	0.000128	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ENO1—breast cancer	2.92e-06	0.000128	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2D6—breast cancer	2.87e-06	0.000126	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOA2—breast cancer	2.81e-06	0.000124	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—FASN—breast cancer	2.73e-06	0.00012	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—BCHE—breast cancer	2.72e-06	0.000119	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC5A5—breast cancer	2.68e-06	0.000118	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC2A1—breast cancer	2.59e-06	0.000114	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NQO1—breast cancer	2.59e-06	0.000114	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1B1—breast cancer	2.49e-06	0.000109	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.44e-06	0.000107	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOA1—breast cancer	2.37e-06	0.000104	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CA—breast cancer	2.36e-06	0.000104	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—STK11—breast cancer	2.34e-06	0.000103	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP19A1—breast cancer	2.34e-06	0.000103	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—COMT—breast cancer	2.17e-06	9.55e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTP1—breast cancer	2.16e-06	9.5e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMOX1—breast cancer	2.13e-06	9.37e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ITPR1—breast cancer	2.13e-06	9.35e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCB1—breast cancer	2.05e-06	9e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TYMS—breast cancer	2.01e-06	8.84e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTM1—breast cancer	1.99e-06	8.73e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.99e-06	8.73e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOR1—breast cancer	1.99e-06	8.73e-05	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKT1—breast cancer	1.93e-06	8.48e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GPX1—breast cancer	1.9e-06	8.36e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1A1—breast cancer	1.88e-06	8.28e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ERCC2—breast cancer	1.87e-06	8.21e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTHFR—breast cancer	1.76e-06	7.72e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CAV1—breast cancer	1.62e-06	7.12e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CG—breast cancer	1.48e-06	6.48e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CD—breast cancer	1.3e-06	5.7e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALB—breast cancer	1.28e-06	5.63e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NOS3—breast cancer	1.22e-06	5.38e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CB—breast cancer	1.13e-06	4.97e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTGS2—breast cancer	1.12e-06	4.92e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTEN—breast cancer	9.77e-07	4.29e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CA—breast cancer	6.89e-07	3.03e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKT1—breast cancer	5.63e-07	2.47e-05	CbGpPWpGaD
